Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Marco Marino in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Valentina Cirello in
Google Scholar
PubMed
Search for other papers by Valentina Gnarini in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Elisa Pignatti in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Livio Casarini in
Google Scholar
PubMed
Search for other papers by Chiara Diazzi in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Vincenzo Rochira in
Google Scholar
PubMed
Search for other papers by Katia Cioni in
Google Scholar
PubMed
Search for other papers by Bruno Madeo in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Cesare Carani in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Introduction Thyroid cancers can be well-differentiated, as papillary and follicular subtypes, or poorly differentiated and anaplastic carcinomas. Papillary thyroid carcinoma (PTC) represents up to 80% of all the thyroid cancer cases. Various
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Introduction Thyroid hormones are one of the most prescribed drugs in Western countries, mostly for the management of hypothyroidism either spontaneous or after thyroidectomy for benign diseases and differentiated thyroid cancer (DTC). The aim
Search for other papers by Yuntao Song in
Google Scholar
PubMed
Search for other papers by Jiaxin Wang in
Google Scholar
PubMed
Search for other papers by Yanli Zhu in
Google Scholar
PubMed
Search for other papers by Guohui Xu in
Google Scholar
PubMed
Search for other papers by Tianxiao Wang in
Google Scholar
PubMed
Search for other papers by Bin Zhang in
Google Scholar
PubMed
Introduction The incidence-based mortality rates of thyroid cancer continued to increase over the past few decades, with papillary thyroid cancer (PTC) being the most common histology ( 1 ). Recurrent or persistent metastasis of the neck lymph
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Search for other papers by Mubashir Mulla in
Google Scholar
PubMed
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Search for other papers by Klaus-Martin Schulte in
Google Scholar
PubMed
Introduction Papillary thyroid cancer (PTC) is the most common thyroid cancer. Metastases from PTC most commonly involve the cervical lymph nodes (CLNs). The incidence of CLN metastases (CLNM) is reported between 30 and 80% (1, 2) . Some studies
Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Thomas Crezee in
Google Scholar
PubMed
Search for other papers by Mirela Petrulea in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Doina Piciu in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Jan W A Smit in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Theo S Plantinga in
Google Scholar
PubMed
Endocrinology Clinic, Cluj County Emergency Hospital, Cluj-Napoca, Romania
Search for other papers by Carmen E Georgescu in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Background In recent years, the incidence of non-medullary thyroid cancer (NMTC) has steadily increased ( 1 , 2 , 3 , 4 ). Although most NMTC patients have a favorable prognosis, 20–30% of patients with locally advanced or metastatic
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Jes Sloth Mathiesen in
Google Scholar
PubMed
Search for other papers by Jens Peter Kroustrup in
Google Scholar
PubMed
Steno Diabetes Center North Jutland, Aalborg, Denmark
Search for other papers by Peter Vestergaard in
Google Scholar
PubMed
Search for other papers by Per Løgstrup Poulsen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Sten Schytte in
Google Scholar
PubMed
Search for other papers by Stefano Christian Londero in
Google Scholar
PubMed
Search for other papers by Henrik Baymler Pedersen in
Google Scholar
PubMed
Search for other papers by Christoffer Holst Hahn in
Google Scholar
PubMed
Search for other papers by Jens Bentzen in
Google Scholar
PubMed
Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark
Search for other papers by Sören Möller in
Google Scholar
PubMed
Search for other papers by Mette Gaustadnes in
Google Scholar
PubMed
Search for other papers by Maria Rossing in
Google Scholar
PubMed
Search for other papers by Finn Cilius Nielsen in
Google Scholar
PubMed
Search for other papers by Kim Brixen in
Google Scholar
PubMed
Search for other papers by Christian Godballe in
Google Scholar
PubMed
Search for other papers by Danish Thyroid Cancer Group (DATHYRCA) in
Google Scholar
PubMed
between January 1960 and December 2014, was constructed through three nationwide registries: the Danish Thyroid Cancer Database, the Danish Cancer Registry and the Danish Pathology Register ( 13 , 14 , 15 ). This has been described in detail previously
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Jes Sloth Mathiesen in
Google Scholar
PubMed
Search for other papers by Jens Peter Kroustrup in
Google Scholar
PubMed
Search for other papers by Peter Vestergaard in
Google Scholar
PubMed
Center for Rare Diseases, Aarhus University Hospital, Aarhus N, Denmark
Search for other papers by Kirstine Stochholm in
Google Scholar
PubMed
Search for other papers by Per Løgstrup Poulsen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Sten Schytte in
Google Scholar
PubMed
Search for other papers by Stefano Christian Londero in
Google Scholar
PubMed
Search for other papers by Henrik Baymler Pedersen in
Google Scholar
PubMed
Search for other papers by Christoffer Holst Hahn in
Google Scholar
PubMed
Search for other papers by Bjarki Ditlev Djurhuus in
Google Scholar
PubMed
Search for other papers by Jens Bentzen in
Google Scholar
PubMed
Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark
Search for other papers by Sören Möller in
Google Scholar
PubMed
Search for other papers by Mette Gaustadnes in
Google Scholar
PubMed
Search for other papers by Maria Rossing in
Google Scholar
PubMed
Search for other papers by Finn Cilius Nielsen in
Google Scholar
PubMed
Search for other papers by Kim Brixen in
Google Scholar
PubMed
Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
Search for other papers by Anja Lisbeth Frederiksen in
Google Scholar
PubMed
Search for other papers by Christian Godballe in
Google Scholar
PubMed
Search for other papers by the Danish Thyroid Cancer Group (DATHYRCA) in
Google Scholar
PubMed
/17801). Methods The MTC cohort was based on the Danish Cancer Registry, the Danish Pathology Register and the Danish Thyroid Cancer Database, which have prospectively collected data since 1943, 1968 and 1996, respectively. The first year, in which registration
Search for other papers by Mahmoud Al-Masri in
Google Scholar
PubMed
Search for other papers by Tawfiq Al-Shobaki in
Google Scholar
PubMed
Search for other papers by Hani Al-Najjar in
Google Scholar
PubMed
Search for other papers by Rafal Iskanderian in
Google Scholar
PubMed
Search for other papers by Enas Younis in
Google Scholar
PubMed
Search for other papers by Niveen Abdallah in
Google Scholar
PubMed
Search for other papers by Abdelghani Tbakhi in
Google Scholar
PubMed
Search for other papers by Hussam Haddad in
Google Scholar
PubMed
Search for other papers by Mohammad Al-Masri in
Google Scholar
PubMed
Search for other papers by Zeinab Obeid in
Google Scholar
PubMed
Search for other papers by Awad Jarrar in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) is the most prevalent subtype of thyroid cancer accounting for approximately 85–88% of cases. The incidence of PTC is rapidly increasing, in contrast to other subtypes ( 1 ). The increase in the
EA GETBO 3878, University Hospital of Brest, Brest, France
Search for other papers by Philippe Thuillier in
Google Scholar
PubMed
EA GETBO 3878, University Hospital of Brest, Brest, France
Search for other papers by Nathalie Roudaut in
Google Scholar
PubMed
EA GETBO 3878, University Hospital of Brest, Brest, France
Search for other papers by Geneviève Crouzeix in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital of Brest, Brest, France
Search for other papers by Marie Cavarec in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital of Brest, Brest, France
Search for other papers by Philippe Robin in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital of Brest, Brest, France
Search for other papers by Ronan Abgral in
Google Scholar
PubMed
EA GETBO 3878, University Hospital of Brest, Brest, France
Search for other papers by Véronique Kerlan in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital of Brest, Brest, France
Search for other papers by Pierre-Yves Salaun in
Google Scholar
PubMed
clinical thyroid cancer risk factors (age >65 years, male gender), PET–CT parameters (SUVmax median), US characteristics (4 majors malignancy criteria defined as presence of marked hypoechogenicity, irregular margins, more tall than wide dimension and
Search for other papers by M Ingenwerth in
Google Scholar
PubMed
Search for other papers by T Brandenburg in
Google Scholar
PubMed
Search for other papers by D Führer-Sakel in
Google Scholar
PubMed
Search for other papers by M Goetz in
Google Scholar
PubMed
Search for other papers by F Weber in
Google Scholar
PubMed
Search for other papers by H Dralle in
Google Scholar
PubMed
Search for other papers by H-U Schildhaus in
Google Scholar
PubMed
Search for other papers by K W Schmid in
Google Scholar
PubMed
Search for other papers by S Theurer in
Google Scholar
PubMed
thyroid cancer-associated deaths ( 1 , 2 ). They can occur either as part of hereditary syndromes (<30% of all MTC) in multiple endocrine neoplasias (MEN) 2A or 2B with germline mutations in the RET proto-oncogene or as sporadic tumors with approximately